Clinical Trial Update: Bone Metastasis on the Survival of Gefitinib Effective Patients [NA]

View source ↗

Summary

A completed clinical trial update examining the impact of bone metastasis on survival outcomes in non-small cell lung cancer patients treated with gefitinib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Overal Survival, Non-small Cell Lung Cancer | NA | Status: COMPLETED